| Literature DB >> 35468567 |
Charlotte M Horne1, Angad Sahni1, Sze W Pang1, Lucy D Vanes1, Timea Szentgyorgyi1, Bruno Averbeck2, Rosalyn J Moran1, Sukhwinder S Shergill3.
Abstract
BACKGROUND: Positive symptoms of psychosis (e.g., hallucinations) often limit everyday functioning and can persist despite adequate antipsychotic treatment. We investigated whether poor cognitive control is a mechanism underlying these symptoms.Entities:
Keywords: Cognitive control; Positive symptoms; Psychosis; Reward learning; fMRI
Mesh:
Substances:
Year: 2022 PMID: 35468567 PMCID: PMC9059151 DOI: 10.1016/j.nicl.2022.103004
Source DB: PubMed Journal: Neuroimage Clin ISSN: 2213-1582 Impact factor: 4.891
Fig. 1Overview of reward learning task and behaviour. A) shows schematic of the fMRI task where participants learnt to associate one of two facial expressions with a 60% chance of being rewarded. There were two conditions; emotional (choice between happy and angry faces) and neutral (choice between neutral faces of different identities). B) shows a box plot of the mean proportion of ideal choices made in each condition by healthy controls (HC), high symptom (HS) and low symptom (LS) groups. There is a main effect of group where HC make more ideal choices than both patient groups (* = p < 0.05). All groups perform significantly above chance level (shown by red dashed line at 0.5) with a one-sample t-test. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
Table of demographic and clinical variables.
| Demographics | Group statistics | |||||||
|---|---|---|---|---|---|---|---|---|
| Age | 33.9 | 9.7 | 26.8 | 5.4 | 26.4 | 6.1 | 14.58 (2, 132) | <0.001 * |
| Sex (number of males) | 26 | 21 | 48 | 1.96 (4) | 0.743 | |||
| IQ (WASI) | 117.9 | 11.6 | 97.5 | 16.0 | 99.9 | 16.9 | 19.94 (2, 124) | <0.001 * |
| Age of onset (years) | 25.1 | 5.5 | 25.2 | 6.5 | −0.10 (65.89) | 0.919 | ||
| Illness duration (years) | 1.8 | 1.1 | 1.6 | 1.3 | 0.92 (67.02) | 0.36 | ||
| Medication dose (CPZ equivalent) | 242.2 | 139.5 | 240 | 142.1 | 0.07 (59.81) | 0.942 | ||
| PANSS Positive | 18.7 | 5.1 | 10.4 | 2.9 | 8.24 (36.93) | <0.0001 * | ||
| PANSS Negative | 16.1 | 5.7 | 11.2 | 4.2 | 4.11 (42.03) | <0.0001 * | ||
| PANSS General | 35.7 | 7.8 | 26.6 | 6.2 | 5.55 (44.77) | <0.0001 * | ||
| PANSS Total | 70.5 | 13.9 | 48.2 | 11.4 | 7.56 (45.73) | <0.0001 * | ||
Means (M) and standard deviations (SD) are shown for each group. HC = healthy controls, HS = high symptom patients, LS = low symptom patients, CPZ = chlorpromazine, df = degrees of freedom, WASI = Wechsler Abbreviated Scale of Intelligence, * highlights significant differences between groups (p < 0.05) where HC were older and had higher IQ than both HS and LS groups. IQ data was missing for 12 participants (n = 37 HC, 26 HS, 62 LS). Variables compared using independent sample t-tests report statistics assuming variances are not equal (according to Levene’s test for equality of variances).
Fig. 2Contrast-related activity in healthy control group. Whole-brain related activity (red/yellow = activation, blue/green = deactivation) associated with the decision and feedback phases of the task during (A) the neutral condition and (B) emotional-neutral contrast. Images presented using a cluster-level statistical threshold of p < 0.05 FWE-corrected and vertical colour bars represent associated T values. Light blue arrows represent the iterative nature of the task where decisions inform feedback responses and in turn the feedback updates decisions. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
Fig. 3Group differences in activity during neutral condition. The top row shows three clusters that are significantly different in patients compared to healthy controls: A) occipital pole/lingual gyrus (neutral decision), B) rostral ACC (neutral feedback), and C) left pre-central gyrus extending into left supplementary motor cortex (neutral feedback). Vertical colour bars indicate the associated T values. The bottom row shows one cluster that is significantly different between HS and LS patient groups: D) SMA/pre-SMA (neutral decision), and associated F value. A bar chart (right) shows the associated parameter estimates for each group (HC = healthy controls, HS = high symptom group, LS = low symptom group) where the horizontal lines indicate the post-hoc significant differences between groups (* = p < 0.05 FWE-corrected). A significant correlation between parameter estimates (from SMA/pre-SMA) and positive symptoms is also presented.
Fig. 4Group differences in activity during emotional – neutral contrast. Displayed are three clusters showing significant differences between HS and LS groups: A) left amygdala (decision), B) left thalamus (feedback) and C) left pallidum (feedback). The vertical colour bars indicate associated F values. The bar charts to the right show the associated parameter estimates for each group (HC = healthy controls, HS = high symptom group, LS = low symptom group) and post-hoc differences between groups (* = p < 0.05 FWE-corrected). Also shown to the right are the significant correlations between the parameter estimates (for each region) and symptoms (red = positive, orange = negative symptoms). There were no significant differences between HC and patients (HS and LS groups combined). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)